term survival was significantly decreased for patients diagnosed with either frailty alone or both frailty and sarcopenia who underwent both surgical (Fig, A) and nonsurgical management (Fig, B) . In multivariate regression models, frailty was the only independent variable (hazard ratio, 7.7; 95% confidence interval, 3.2-18.7; P < .001) that predicted mortality.
Comparison of Bovine Carotid Xenograft Versus Expanded Polytetrafluoroethylene Grafts for Forearm Loop Hemodialysis Access
Objective: Forearm loop grafts are a useful option for dialysis access in patients without suitable forearm veins. Bovine carotid artery (BCA) and expanded polytetrafluoroethylene (ePTFE) grafts are commonly used for this purpose, but no data exist to support the use of one over the other in the forearm loop conformation.
Methods: We performed a retrospective review of 57 forearm loop grafts implanted at two institutions with a shared patient population between January 2009 and May 2017. Primary and secondary patency rates were calculated by univariate analysis and a Cox regression model adjusted for age, sex, and body mass index.
Results: There were 26 BCA and 31 ePTFE grafts placed during the study period. Mean follow-up was 37 6 25 months. Primary and secondary patency rates in the BCA group were 71.7% and 83.6%, 54.8% and 71.1%, and 28.9% and 62.2% at 6, 12, and 24 months, respectively. In the ePTFE group, primary and secondary patency rates were 56.8% and 66.7%, 39.3% and 59.7%, and 26.9% and 40.4% at 6, 12, and 24 months (Fig) . When adjusted for age, sex, and body mass index, secondary patency was significantly better with BCA compared with ePTFE (P ¼ .04). Infection rates were 7% (two grafts) for BCA and 3% (one graft) for ePTFE.
Conclusions: Bovine carotid xenografts in forearm loop configuration for hemodialysis access have improved secondary patency and similar infection rates compared with ePTFE forearm loops. Author Disclosures: B. Colvard: Nothing to disclose; K. Lavignia: Nothing to disclose; V. T. Ho: Nothing to disclose; N. Itoga: Nothing to disclose; A. Dua: Nothing to disclose; E. J. Harris: Nothing to disclose; M. Mell: Nothing to disclose; E. Sorial: Nothing to disclose; M. Garcia-Toca: Nothing to disclose.
Disease-Based Observation Cohort Study of Patients with Thoracoabdominal Aortic Aneurysm
Chulhi Kang, Matthew A. Bartek, Sherene Shalhub, Derek P. Nathan, Matthew P. Sweet. University of Washington, Seattle, Wash
Objective: Current understanding of thoracoabdominal aortic aneurysms (TAAAs) is limited to case series and administrative data describing patients selected to undergo surgical repair. Little is known about the overall cohort of patients with TAAA, specifically those not selected for repair. The purpose of this study was to describe a disease-based cohort of patients with TAAA.
Methods: An academic multihospital institutional database was screened by diagnosis codes for TAAA from 2009 to 2017 using the International Classification of Diseases, Ninth Revision and Tenth Revision. Diagnosis was then confirmed or rejected by chart review and the CT finding of aneurysmal degeneration >3.2 cm of the paravisceral aorta in continuity with aneurysmal aorta meeting standard criteria for repair. Patients younger than 18 years and those with mycotic aneurysm were excluded. Patients underwent four broad categories of repair: open; endovascular with branched grafts; hybrid, defined as visceral debranching followed by thoracic endovascular aortic repair; and incomplete repair, in which the paravisceral segment was intentionally left unaddressed. The primary outcome measure for those receiving an operation was a composite measure of "good" outcome, defined as survival at 1 year, return to preoperative functional status, and freedom from permanent loss of organ system function.
Results: There were 406 patients who met the inclusion criteria. Demographic data and composite good outcomes are reported in the Table. 
